Cardiothoracic surgery stands at the forefront of medical innovation, specializing in intricate surgical interventions within the chest cavity. This dynamic field encompasses a spectrum of procedures ranging from addressing congenital heart anomalies to managing acquired cardiovascular diseases and thoracic malignancies. Exceptionally skilled cardiothoracic surgeons leverage state-of-the-art techniques and advanced technology to perform intricate and often life-saving surgeries. Procedures commonly undertaken include complex interventions like coronary artery bypass grafting, intricate heart valve repair or replacement, lung transplantation, and the correction of congenital anomalies. The field is marked by a continuous evolution, embracing innovations such as minimally invasive approaches, robotic-assisted surgery, and advancements in perioperative care. Serving as an integral component of cardiovascular medicine, cardiothoracic surgery remains pivotal in elevating patient outcomes and enhancing the quality of life for individuals confronting challenging cardiac and thoracic conditions.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States